Preischemic iloprost application for improvement of graft preservation: which route is superior in experimental pig lung transplantation: inhaled or intravenous?

Transplant Proc. 2007 Jun;39(5):1345-9. doi: 10.1016/j.transproceed.2007.03.065.

Abstract

Background: Optimal allograft protection is essential in lung transplantation to reduce postoperative organ dysfunction. Although intravenous prostanoids are routinely used to ameliorate reperfusion injury, the latest evidence suggests a similar efficacy of inhaled prostacyclin. Therefore, we compared donor lung-pretreatment using inhaled lioprost (Ventavis) with the commonly used intravenous technique.

Methods: Five pig lungs were each preserved with Perfadex and stored for 27 hours without (group 1) or with (group-2, 100 prior aerosolized of iloprost were (group 3) or iloprost (IV). Following left lung transplantation, hemodynamics, Po(2)/F(i)o(2), compliance, and wet-to-dry ratio were monitored for 6 hours and compared to sham controls using ANOVA analysis with repeated measures.

Results: The mortality was 100% in group 3. All other animals survived (P < .001). Dynamic compliance and PVR were superior in the endobronchially pretreated iloprost group as compared with untreated organs (P < .05), whereas oxygenation was comparable overall W/D-ratio revealed significantly lower lung water in group 2 (P = .027) compared with group 3.

Conclusion: Preischemic alveolar deposition of iloprost is superior to IV pretreatment as reflected by significantly improved allograft function. This strategy offers technique to optimize pulmonary preservation.

MeSH terms

  • Administration, Inhalation
  • Animals
  • Graft Survival / drug effects*
  • Iloprost / administration & dosage
  • Iloprost / therapeutic use*
  • Injections, Intravenous
  • Lung Transplantation / adverse effects
  • Lung Transplantation / physiology*
  • Models, Animal
  • Platelet Aggregation Inhibitors / therapeutic use
  • Reperfusion Injury / prevention & control*
  • Swine

Substances

  • Platelet Aggregation Inhibitors
  • Iloprost